Neoadjuvant Treatment for Squamous Carcinoma of the Thoracic Esophagus
Cancer of the esophagus has a poor prognosis. Survival rates appear to be correlated with depth of tumor invasion (T), lymph node involvement (N) and the presence of distant metastases (M). The biological behavior of the disease, characterized by early regional lymphatic spread, make it a systemic disease and explains the poor results of surgery and radiotherapy. In the last 20 years, survival rates for esophageal cancer have been less than 10% [1–2]. To obtain better results, several authors suggested many trials of different treatments including chemotherapy.
KeywordsEsophageal Cancer Esophageal Squamous Cell Carcinoma Esophageal Carcinoma Squamous Carcinoma Thoracic Esophagus
Unable to display preview. Download preview PDF.
- 3.Kelsen DP, Bains M, Hilaris B (1981) Cisplatin-based preoperative chemotherapy of esophageal carcinoma in adjuvant therapy of cancer. In: Salomon S, Jones (eds) Grune and Stratton, New York, pp 495–502Google Scholar
- 6.Japanese Committee for Registration of Esophageal Carcinoma (1985) A proposal for a new TNM classification of esophageal carcinoma. Jpn J Clin Oncol 14: 655–662Google Scholar
- 12.McFarlane SD, Lucius DH, Jolly PC, Kozarek RA, Anderson RP (1988) Improved results of surgical treatment for esophageal and gastroesophageal junction carcinomas after preoperative combined chemotherapy and radiation. J Thorac Cardiovasc Surg 95: 415–22Google Scholar
- 15.Peracchia A, Debesi B, Castoro C (1989) Results of surgery after cisplatin and 5-fluorouracil combination chemotherapy for locally advanced esophageal squamous cell carcinoma. Fourth world congress of the International Society for Diseases of the Esophagus. Chicago, SeptemberGoogle Scholar
- 16.Campbell WR, Taylor SA, Pierce GE, Hermrelk AS, Thomas JH (1985) Therapeutic alternative in patients with esophageal cancer. Annual meeting Southwestern Surgical Congress, Las Vegas, AprilGoogle Scholar
- 18.Stewart FM, Poplin E, Fleming T, Leichman L (1987) Combined therapies for squamous cell carcinoma of the esophagus: a Southwest Oncology Group Study (SWOG-8037). J Clin Oncol 5: 622–628Google Scholar